- Acquired Kokomodo Ltd., Apr 2025
- Raised $30M Public Offering, Feb 2021
- Raised $50M debt round, Apr 2020
About
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli biotechnology company engaged in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. It also offers cell manufacturing services and cell-based coffee, and develops and commercializes cultivated meat products. Pluri operates in the fields of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech, utilizing its unique three-dimensional (3D) technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice (GMP) cell manufacturing facility. [5, 11, 23]
Funding history · 18 rounds · $219.8M total
Acquisitions · 1
Offices
Q&A
- What is Pluri's primary business?
- Pluri Inc., formerly Pluristem Therapeutics, is an Israeli biotechnology company focused on the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries, including regenerative medicine, food tech, immunotherapy, CDMO, and AgTech.
- When was Pluri founded and where is its headquarters located?
- Pluri was founded in May 2001 and is headquartered in Haifa, Israel.
- What was Pluri's most recent public offering?
- Pluri completed a public offering in February 2024, raising $10,000,000.
- What was the amount of Pluri's debt financing round in April 2020?
- In April 2020, Pluri secured $50,000,000 in debt financing.
- Which organizations provided grants to Pluri in May 2016?
- In May 2016, Pluri received a $3,300,000 grant from the Israel Innovation Authority and the European Union's Horizon 2020 program.
- What is Pluri's total funding raised to date?
- Pluri has raised a total of $219,843,400 to date.
- Has Pluri made any acquisitions?
- Yes, Pluri acquired Kokomodo Ltd. in April 2025.
Team · 14
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pluri-biotech.com/ |
|---|---|
| linkedin.com/company/pluri-biotech | |
| X / Twitter | twitter.com/Pluribiotech |
Identifiers & details
| Legal name | Pluri Inc. |
|---|---|
| Founded | 2001-5 |
| Employees (exact) | 93 |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Kokomodo Ltd. | 2025-04 |
Radar intelligence
Patents
| EPO | 20 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | pluri-biotech.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513371666 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2003-01-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 7 — people (4), other (1), charge (2) |
| Registered address | מרכז תעשיות מדע ,דואר מת~מ 20 חיפה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-24 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-22 | עדכון דירקטורים-עדכון מנהלים |
| 2025-11-17 | עדכון כתובת ו/או מען דיגיטלי |
| 2025-11-16 | סילוק שעבוד |
| 2026-06-16 | עדכון דירקטורים-הסרת דירקטור |
| 2026-06-16 | עדכון בעלי תפקידים |
| 2026-05-13 | סילוק שעבוד |